HK Stock Market Move | GUAN CHAO HLDGS(01872) fell more than 50% at one point during trading, issuing 4.32 billion shares for rights issue at a ratio of 1 for 4.
Crown Holdings (01872) fell more than 50% at one point during the trading day, and as of the time of writing, it has fallen by 39.82%, trading at 0.68 Hong Kong dollars, with a trading volume of 2.8783 million Hong Kong dollars.
GUAN CHAO HLDGS (01872) fell more than 50% at one point in intraday trading, and as of the time of writing, it had fallen by 39.82% to 0.68 Hong Kong dollars, with a trading volume of 2.8783 million Hong Kong dollars.
In terms of news, GUAN CHAO HLDGS announced that for every 1 share held, shareholders will be entitled to 4 rights shares at a subscription price of 0.40 Hong Kong dollars per rights share, resulting in the issuance of 4.32 billion rights shares.
Previously, GUAN CHAO HLDGS announced that the company is expected to have a profit attributable to equity holders of approximately 0.9 million Singapore dollars for the six months ending on June 30, 2024, compared to 6.4 million Singapore dollars in the same period in 2023. Based on the financial data mentioned above, the decrease in profit is mainly attributed to a decrease in revenue due to reduced customer demand. The decrease in revenue in 2024 is also due to the fact that the price of vehicle certificates remains at a high level, leading to a decrease in market demand.
Related Articles
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


